Research Opportunities

Partnering for New Findings

Clinical trials are a major step to translate pharmacological potential into clinical safety & efficacy

  • =NeuroAiD™, our first product for post-stroke recovery, was commercialized for the first time in Singapore in 2006.
  • =It is today available in over 35 countries in South-East Asia, Europe, Africa and Middle-East.

We bring together the world’s top scientists’ in molecular biology, pharmacology and brain injuries to conduct our research and development on the principles of Evidence-Based Medicine.

The research on NeuroAiD™ is still very active

The research on NeuroAiD™ is still very active in post-stroke recover but also in new indications for NeuroAiD™ such as traumatic brain injuries and neurodegenerative diseases (i.e. Alzheimer disease). On average, 4 to 5 papers are published each year by independent researchers, and communicated in international conferences on stroke.

Contact Us

If you represent an institution interested in academic partnerships for clinical trial in:

  • =Post Stroke Recovery
  • =Neurosurgical Diseases
  • =Neurodegenerative Diseases

Please contact us at [email protected]

We will be pleased to have you and your team extending the knowledge of our innovative and promising products.

Clinical Partnership

This form will be sent directly to [email protected] for Research Opportunities.

  • This field is for validation purposes and should be left unchanged.